Two Hot Stocks on the Run: HDFC Bank Limited (NYSE:HDB), Cymabay Therapeutics, Inc. (NASDAQ:CBAY)

HDFC Bank Limited (NYSE:HDB)

The shares of HDFC Bank Limited (NYSE:HDB) started off the last trading session with the price of $96.79 while closing the day with the price of $97.45. The shares of HDFC Bank Limited (NYSE:HDB) Rise 1.1% with the Gain of 0.66 points.

The shares of HDFC Bank Limited (NYSE:HDB) traded with the day volume of 394303 shares whereas its average trading volume is 653.41 Million.

While analyzing the past performance of the stock we can see that the shares of HDFC Bank Limited (NYSE:HDB) Gain 0.28% in the last week while Falling -0.08% in the last month. Past quarter performance shows the green light with 2.58%. The semi-annual and annual performance shows 0.02% and 36.58% respectively.

Some critical values of the shares of HDFC Bank Limited (NYSE:HDB) to be discussed here are: the beta which shows the value at 1.05 while Average True Range of HDFC Bank Limited (NYSE:HDB) demonstrate the value at 2.01. The weekly and monthly volatility of the shares of HDFC Bank Limited (NYSE:HDB) are indicated at 1.28% and 1.68%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 45.52.

While studying the financial position of the shares of HDFC Bank Limited (NYSE:HDB), we can see that the Market capitalization of the company is at 74.85 Billion. The shares outstanding for the company is 768.09 Million and the shares float stands at 654.53 Million. The income of the company stand at 2.43 Billion while the sales stand at 11.94 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 2.81, Price to Earnings or P/E is at 34.69, Price to Sales P/S show the value of 6.27, the Return on Asset ROA stood at 0 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at 0.134.


Cymabay Therapeutics, Inc. (NASDAQ:CBAY)

Cymabay Therapeutics, Inc. (NASDAQ:CBAY) started its previous trading session at $15.08 and closed at $14 showing a Fell of -6.6 Percent.

The Company traded with an average Volume of 904.65 Million whereas, its Day Volume stood at 862565.

Looking at the performance of the stock, Cymabay Therapeutics, Inc. (NASDAQ:CBAY) Loss -6.35% in the last week in its shares price and 16.67% in the last month. Quarterly performance shows a green of 69.29 Percent while Semi-Annual and Annual performances shows a 135.29 and 250.88 percent respectively.

Beta for Cymabay Therapeutics, Inc. (NASDAQ:CBAY) stands at 1.86 while the ATR (average true range) is at 0.97. The Stock’s Weekly and Monthly Volatility is 7.28% and 6.88% respectively showing a RSI value of 53.16.

While studying the financial position of the shares of Cymabay Therapeutics, Inc. (NASDAQ:CBAY), we can see that the Market capitalization of the company is at 741.58 Million. The shares outstanding for the company is 52.97 Million and the shares float stands at 52.97 Million.

The Company generated an income of -29500000 and the sales of 4.8 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.01 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 154.5 respectively.

The Return on Assets stands at -0.702, ROE shows a value of -1.158 and ROI for Cymabay Therapeutics, Inc. (NASDAQ:CBAY) is 0 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment